Vitamin D status and changes in cardiovascular risk factors: A prospective study of a general population

Cardiology (Switzerland)

Volumn 123, Issue 1, 2012, Pages 62-70

  Skaaby, Tea ^a   Husemoen, Lise Lotte Nystrup ^a   Pisinger, Charlotta ^a   Jørgensen, Torben ^a,b   Thuesen, Betina Heinsbæk ^a   Fenger, Mogens ^c   Linneberg, Allan ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Blood pressure; Cardiovascular disease; Cardiovascular risk factors; Cholesterol; Hypercholesterolemia; Hypertension; Lipids; Metabolic syndrome; Prospective study; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL; VITAMIN D;

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

ADULT; BLOOD PRESSURE; CHROMATOGRAPHY, LIQUID; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84866153576     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000341277     Document Type: Article

References (67)

1. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al: Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008; 117: 503-511.
2. Ginde AA, Scragg R, Schwartz RS, Camargo CA Jr: Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 2009; 57: 1595-1603.
3. Hosseinpanah F, Yarjanli M, Sheikholeslami F, Heibatollahi M, Eskandary PS, Azizi F: Associations between vitamin D and cardiovascular outcomes; Tehran Lipid and Glucose Study. Atherosclerosis 2011; 218: 238-242.
4. Pilz S, Dobnig H, Nijpels G, Heine RJ, Stehouwer CD, Snijder MB, et al: Vitamin D and mortality in older men and women. Clin Endocrinol (Oxf) 2009; 71: 666-672.
5. Semba RD, Houston DK, Bandinelli S, Sun K, Cherubini A, Cappola AR, et al: Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr 2010; 64: 203-209.
6. Vacek JL, Vanga SR, Good M, Lai SM, Lakkireddy D, Howard PA: Vitamin D deficiency and supplementation and relation to cardiovascular health. Am J Cardiol 2012; 109: 359-363.
7. Muldowney S, Kiely M: Vitamin D and cardiometabolic health: a review of the evidence. Nutr Res Rev 2010, pp 1-20.
8. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ: Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747-1757.
9. Després JP, Poirier P, Bergeron J, Tremblay A, Lemieux I, Almeras N: From individual risk factors and the metabolic syndrome to global cardiometabolic risk. Eur Heart J Suppl 2008; 10(suppl B):B24-B33.
10. Grundy SM: A changing paradigm for prevention of cardiovascular disease: emergence of the metabolic syndrome as a multiplex risk factor. Eur Heart J Suppl 2008; 10(suppl B):B16-B23.
11. Alberti KG, Zimmet P, Shaw J: The metabolic syndrome-a new worldwide definition. Lancet 2005; 366: 1059-1062.
12. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 2004; 24:e13-e18.
13. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J: Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 2004; 89-90: 387-392.
14. Tomaschitz A, Pilz S, Ritz E, Grammer T, Drechsler C, Boehm BO, et al: Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Clin Chim Acta 2010; 411: 1354-1360.
15. Zagura M, Serg M, Kampus P, Zilmer M, Eha J, Unt E, et al: Aortic stiffness and vitamin D are independent markers of aortic calcification in patients with peripheral arterial disease and in healthy subjects. Eur J Vasc Endovasc Surg 2011; 42: 689-695.
16. Chiu KC, Chu A, Go VL, Saad MF: Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79: 820-825.
17. Zittermann A, Frisch S, Berthold HK, Gotting C, Kuhn J, Kleesiek K, et al: Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009; 89: 1321-1327.
18. Cho HJ, Kang HC, Choi SA, Ju YC, Lee HS, Park HJ: The possible role of Ca 2+ on the activation of microsomal triglyceride transfer protein in rat hepatocytes. Biol Pharm Bull 2005; 28: 1418-1423.
19. Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC: Regulation of adiposity by dietary calcium. FASEB J 2000; 14: 1132-1138.
20. Hypponen E, Boucher BJ, Berry DJ, Power C: 25-Hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes 2008; 57: 298-305.
21. Jorde R, Figenschau Y, Hutchinson M, Emaus N, Grimnes G: High serum 25-hydroxyvitamin D concentrations are associated with a favorable serum lipid profile. Eur J Clin Nutr 2010; 64: 1457-1464.
22. Jorde R, Grimnes G: Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res 2011; 50: 303-312.
23. Maki KC, Rubin MR, Wong LG, McManus JF, Jensen CD, Marshall JW, et al: Serum 25-hydroxyvitamin D is independently associated with high-density lipoprotein cholesterol and the metabolic syndrome in men and women. J Clin Lipidol 2009; 3: 289-296.
24. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, et al: Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2007; 167: 1159-1165.
25. Botella-Carretero JI, Alvarez-Blasco F, Villafruela JJ, Balsa JA, Vázquez C, Escobar-Morreale HF: Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr 2007; 26: 573-580.
26. Ford ES, Ajani UA, McGuire LC, Liu S: Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005; 28: 1228-1230.
27. Lee DM, Rutter MK, O'Neill TW, Boonen S, Vanderschueren D, Bouillon R, et al: Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men. Eur J Endocrinol 2009; 161: 947-954.
28. Reis JP, von Mühlen D, Kritz-Silverstein D, Wingard DL, Barrett-Connor E: Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in communitydwelling older adults. Diabetes Care 2007; 30: 1549-1555.
29. Reis JP, von Mühlen D, Miller ER III: Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol 2008; 159: 41-48.
30. Rueda S, Fernández-Fernández C, Romero F, Martinez de Osaba J, Vidal J: Vitamin D, PTH, and the metabolic syndrome in severely obese subjects. Obes Surg 2008; 18: 151-154.
31. Burgaz A, Orsini N, Larsson SC, Wolk A: Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J Hypertens 2011; 29: 636-645.
32. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ: Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes 2008; 57: 2619-2625
33. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, et al: Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007; 49: 1063-1069.
34. Forman JP, Curhan GC, Taylor EN: Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension 2008; 52: 828-832.
35. Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, et al: Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 2010; 106: 963-968.
36. Jorde R, Sneve M, Torjesen P, Figenschau Y: No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med 2010; 267: 462-472.
37. Scragg R, Khaw KT, Murphy S: Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. Eur J Clin Nutr 1995; 49: 640-646.
38. Maki KC, Rubin MR, Wong LG, McManus JF, Jensen CD, Lawless A: Effects of vitamin D supplementation on 25-hydroxyvitamin D, high-density lipoprotein cholesterol, and other cardiovascular disease risk markers in subjects with elevated waist circumference. Int J Food Sci Nutr 2011; 62: 318-327.
39. Scragg R, Wishart J, Stewart A, Ofanoa M, Kerse N, Dyall L, et al: No effect of ultraviolet radiation on blood pressure and other cardiovascular risk factors. J Hypertens 2011; 29: 1749-1756.
40. Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD: Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet Med 2008; 25: 320-325.
41. Witham MD, Nadir MA, Struthers AD: Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens 2009; 27: 1948-1954.
42. Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K, et al: Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 2010; 152: 307-314.
43. von Hurst PR, Stonehouse W, Matthys C, Conlon C, Kruger MC, Coad J: Study protocol-metabolic syndrome, vitamin D and bone status in South Asian women living in Auckland, New Zealand: a randomised, placebo-controlled, double-blind vitamin D intervention. BMC Public Health 2008; 8: 267.
44. Jorgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glumer C, Pisinger C: A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur J Cardiovasc Prev Rehabil 2003; 10: 377-386.
45. Toft U, Kristoffersen L, Ladelund S, Bysted A, Jakobsen J, Lau C, et al: Relative validity of a food frequency questionnaire used in the Inter99 study. Eur J Clin Nutr 2008; 62: 1038-1046.
46. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894:i-253.
47. Aadahl M, von Huth SL, Pisinger C, Toft UN, Glumer C, Borch-Johnsen K, et al: Five-year change in physical activity is associated with changes in cardiovascular disease risk factors: the Inter99 study. Prev Med 2009; 48: 326-331.
48. Thuesen B, Husemoen L, Fenger M, Jakobsen J, Schwarz P, Toft U, et al: Determinants of vitamin D status in a general population of Danish adults. Bone 2012; 50: 605-610.
49. Jakobsen J, Bysted A, Andersen R, Bennett T, Brot C, Bugel S, et al: Vitamin D status assessed by a validated HPLC method: within and between variation in subjects supplemented with vitamin D3. Scand J Clin Lab Invest 2009; 69: 190-197.
50. Vickers AJ, Altman DG: Statistics notes: analysing controlled trials with baseline and follow up measurements. BMJ 2001; 323: 1123-1124.
51. Kamycheva E, Jorde R, Figenschau Y, Haug E: Insulin sensitivity in subjects with secondary hyperparathyroidism and the effect of a low serum 25-hydroxyvitamin D level on insulin sensitivity. J Endocrinol Invest 2007; 30: 126-132.
52. Reaven GM: Banting Lecture 1988. Role of insulin resistance in human disease. 1988. Nutrition 1997; 13: 65.
53. Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J, et al: The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 2004; 89: 1196-1199.
54. de ZD, Bakker SJ: Does the metabolic syndrome add to the diagnosis and treatment of cardiovascular disease? Nat Clin Pract Cardiovasc Med 2008; 5(suppl 1):S10-S14.
55. Jorde R, Figenschau Y, Emaus N, Hutchinson M, Grimnes G: Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension. Hypertension 2010; 55: 792-798.
56. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, et al: Primary prevention of hypertension: clinical and public health advisory from the National High Blood Pressure Education Program. JAMA 2002; 288: 1882-1888.
57. Grant WB: Effect of interval between se-rum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level: Implications for meta-analyses and setting vitamin D guidelines. Dermatoendocrinol 2011; 3: 199-204.
58. Jorde R, Sneve M, Hutchinson M, Emaus N, Figenschau Y, Grimnes G: Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol 2010; 171: 903-908.
59. Ocke MC, Schrijver J, Obermann-de Boer GL, Bloemberg BP, Haenen GR, Kromhout D: Stability of blood (pro)vitamins during four years of storage at-20 ° C: consequences for epidemiologic research. J Clin Epidemiol 1995; 48: 1077-1085.
60. Wielders JP, Wijnberg FA: Preanalytical stability of 25(OH)-vitamin D3 in human blood or serum at room temperature: solid as a rock. Clin Chem 2009; 55: 1584-1585.
61. Seamans KM, Cashman KD: Existing and potentially novel functional markers of vitamin D status: a systematic review. Am J Clin Nutr 2009; 89: 1997S-2008S.
62. Ovesen L, Boeing H: The use of biomarkers in multicentric studies with particular consideration of iodine, sodium, iron, folate and vitamin D. Eur J Clin Nutr 2002; 56(suppl 2):S12-S17.
63. Carter GD, Carter CR, Gunter E, Jones J, Jones G, Makin HL, et al: Measurement of vitamin D metabolites: an international perspective on methodology and clinical interpretation. J Steroid Biochem Mol Biol 2004; 89-90: 467-471.
64. Snellman G, Melhus H, Gedeborg R, Byberg L, Berglund L, Wernroth L, et al: Determining vitamin D status: a comparison between commercially available assays. PLoS One 2010; 5:e11555.
65. Carter GD: 25-Hydroxyvitamin D assays: the quest for accuracy. Clin Chem 2009; 55: 1300-1302.
66. Glendenning P, Taranto M, Noble JM, Musk AA, Hammond C, Goldswain PR, et al: Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assayspecific decision limits and metabolite-specific assays. Ann Clin Biochem 2006; 43: 23-30.
67. Lee JH, O'Keefe JH, Bell D, Hensrud DD, Holick MF: Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008; 52: 1949-1956.